Main Navigation

Faculty Search

Make an
appointment

Ask a Question
Refer a Patient

1.877.CALL NJH
(877.225.5654)

New Search

Max Seibold, PhD

Assistant Professor
Office of Academic Affairs
Center for Genes, Environment, and Health
Department of Pediatrics

Profile
Office Information

Profile

Research Areas

Asthma
Epidemiology
Genetics
Genomics
Molecular Genetics
Pulmonary Fibrosis

Programs & Services

Center for Genes, Environment and Health

Gender:: Male

Education & Training

Education

2001: Southwestern Oklahoma State University, Chemistry
2008: University of California-San Francisco, PhD, Pharmaceutical Sciences and Pharmacogenomics
2008-2011: National Jewish Health, Genetics of Pulmonary Fibrosis, Laboratory of Dr. David Schwartz

Special Interests

The Seibold Lab is focused on identifying genetic determinants and biomarkers of complex lung diseases, including asthma and pulmonary fibrosis. Many of the genetic variants that influence development and severity of these lung diseases do so by altering molecular functions in specific lung cell types. His lab is focused on identifying dysregulated molecular functions in patient lung cells, by Nex-Generation sequencing technologies. Using patient cohorts the genetic determinants of these molecular changes are then mapped. The lab is also editing the genome of these lung cells to allow detailed mechanistic studies of disease variants and better understanding of how these genetic changes increase risk of disease development.

Teaching or Professional Positions

2011-present Assistant Professor, CGEH, Department of Pediatrics, National Jewish Health

Industry Relationships & Collaborations

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Publications

A common MUC5B promoter polymorphism and pulmonary fibrosis. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA. N Engl J Med. 2011 Apr 21;364(16):1503-12.

Genetic ancestry in lung-function predictions. *Kumar R, *Seibold MA, *Aldrich MC, *Williams LK, Reiner AP, Colangelo L, Galanter J, Gignoux C, Hu D, Sen S, Choudhry S, Peterson EL, Rodriguez-Santana J, Rodriguez-Cintron W, Nalls MA, Leak TS, O'Meara E, Meibohm B, Kritchevsky SB, Li R, Harris TB, Nickerson DA, Fornage M, Enright P, Ziv E, Smith LJ, Liu K, Burchard EG.N Engl J Med. 2010 Jul 22;363(4):321-30. Epub 2010 Jul 7.

Differential enzymatic activity of common haplotypic versions of the human acidic Mammalian chitinase protein. Seibold MA, Reese TA, Choudhry S, Salam MT, Beckman K, Eng C, Atakilit A, Meade K, Lenoir M, Watson HG, Thyne S, Kumar R, Weiss KB, Grammer LC, Avila P, Schleimer RP, Fahy JV, Rodriguez-Santana J, Rodriguez-Cintron W, Boot RG, Sheppard D, Gilliland FD, Locksley RM, Burchard EG. J Biol Chem. 2009 Jul 17;284(29):19650-8. Epub 2009 May 12.

Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. Seibold MA, Donnelly S, Solon M, Innes A, Woodruff PG, Boot RG, Burchard EG, Fahy JV. J Allergy Clin Immunol. 2008 Nov;122(5):944-950.e3. Epub 2008 Oct 9.